Adaptin Bio has opened enrolment for a Phase I clinical trial to assess its BRiTE therapy, APTN-101, in adults with glioblastoma.

The post Enrolment opens for Adaptin Bio’s Phase I trial of glioblastoma therapy appeared first on Clinical Trials Arena.